Literature DB >> 17657659

Severe reversible cerebral vasoconstriction syndrome mimicking aneurysmal rupture and vasospasm.

Christopher Nickele1, Kenji Muro, Christopher C Getch, Matthew T Walker, Richard A Bernstein.   

Abstract

INTRODUCTION: Presenting symptoms of aneurysmal subarachnoid hemorrhage (SAH) and reversible cerebral vasoconstriction syndrome (RCVS) may overlap. Patients with RCVS often harbor unruptured aneurysms. We report a case of RCVS in a patient with an unruptured intracranial aneurysm. The development of diffuse vasoconstriction after aneursym clipping in the absence of any subarachnoid blood was initially confusing, until subtle vasoconstriction before clipping was seen retrospectively.
RESULTS: We obtained perfusion and diffusion MRI studies on this patient, which shed light on the pathophysiology of RCVS.
CONCLUSION: It is important for physicians who care for patients with aneurysmal SAH to recognize RCVS, as the treatments for these two conditions are different.

Entities:  

Mesh:

Year:  2007        PMID: 17657659     DOI: 10.1007/s12028-007-0001-4

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  10 in total

1.  Thunderclap headache, reversible cerebral arterial vasoconstriction, and unruptured aneurysms.

Authors:  A B Singhal
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-07       Impact factor: 10.154

2.  Postpartum angiopathy and other cerebral vasoconstriction syndromes.

Authors:  Aneesh B Singhal; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Reversible cerebral vasoconstriction syndromes.

Authors:  Richard A Bernstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

4.  Angioplasty for cerebral vasospasm from eclampsia.

Authors:  A J Ringer; A I Qureshi; S H Kim; R D Fessler; L R Guterman; L N Hopkins
Journal:  Surg Neurol       Date:  2001-12

Review 5.  Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke.

Authors:  L R Caplan; M Hennerici
Journal:  Arch Neurol       Date:  1998-11

Review 6.  Reversible cerebral segmental vasoconstriction.

Authors:  G K Call; M C Fleming; S Sealfon; H Levine; J P Kistler; C M Fisher
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

7.  Cerebral vasoconstriction and stroke after use of serotonergic drugs.

Authors:  A B Singhal; V S Caviness; A F Begleiter; E J Mark; G Rordorf; W J Koroshetz
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

Review 8.  Vasculitis of the central nervous system.

Authors:  L H Calabrese
Journal:  Rheum Dis Clin North Am       Date:  1995-11       Impact factor: 2.670

9.  Postpartum angiopathy with reversible posterior leukoencephalopathy.

Authors:  Aneesh B Singhal
Journal:  Arch Neurol       Date:  2004-03

10.  Thunderclap headache: symptom of unruptured cerebral aneurysm.

Authors:  J W Day; N H Raskin
Journal:  Lancet       Date:  1986-11-29       Impact factor: 79.321

  10 in total
  4 in total

Review 1.  Reversible cerebral vasospasm, multilobular intracerebral hemorrhages, and nonaneurysmal subarachnoid hemorrhage: review of possible interrelationships.

Authors:  Philippe Hantson; Patrice Forget
Journal:  Curr Pain Headache Rep       Date:  2010-06

Review 2.  Reversible Cerebral Vasoconstriction Syndrome, Part 2: Diagnostic Work-Up, Imaging Evaluation, and Differential Diagnosis.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

3.  Effects of simvastatin and taurine on delayed cerebral vasospasm following subarachnoid hemorrhage in rabbits.

Authors:  Cheng Lin; Yuanli Zhao; Gang Wan; Anlin Zhu; Hao Wang
Journal:  Exp Ther Med       Date:  2016-02-16       Impact factor: 2.447

Review 4.  A systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based?

Authors:  Emma Devenney; Hazel Neale; Raeburn B Forbes
Journal:  J Headache Pain       Date:  2014-08-14       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.